Manuscript guidelines for submission to the final phase + co-authors summary paper ¶
By: coendevente on Jan. 26, 2022, 1:40 p.m.
For the Final Test Phsae, it is required to include a link to your publication or preprint with a brief description about the method that is used in your submission. We use similar guidelines for the publication or preprint as the first challenge that used Docker submissions through grand-challenge.org, MIDOG2021. It is preferably available on a preprint server of your choice (arxiv.org, medrxiv.org,…). It should be around 2 pages in length and describe:
- What your general algorithmic approach is
- How you trained it
- Any aspect that you think is new and interesting to know 🙂
- (optionally) Your result on Preliminary Test Phase 2
As a reference / example of how your preprint may look like, please have a look at this preprint:
Wilm, F., Breininger, K., Aubreville, M: Domain Adversarial RetinaNet as a Reference Algorithm for the MItosis DOmain Generalization (MIDOG) Challenge, https://arxiv.org/abs/2108.11269
You could use their LateX source code (zip file here). Please make sure to cite the official Rotterdam EyePACS AIROGS train set description (https://doi.org/10.5281/zenodo.5745363) in your publication or preprint.
The link should be included in the Final Phase Submission form under "Publication / Preprint".
The Final Test Phase opens at 08/02/2022, noon CET and closes at 01/03/2022, 23:59 CET.
We aim to write a summary paper about the challenge. The best performing teams will be allowed to choose a maximum of three persons to be co-author in this summary paper.